Acelrx pharmaceuticals to participate in the h.c. wainwright annual investment conference

San mateo, calif. , sept. 6, 2023 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that chief executive officer, vince angotti will present in-person and be available for one-on-one meetings throughout the h.c.
ACRX Ratings Summary
ACRX Quant Ranking